INFUSE SALES LEADING MEDTRONIC SPINE TO HEALTH (Orthopedics This Week)
Medtronic Inc.’s spine’s most recent quarter’s sales beat Wall Street expectations. Most surprisingly, Infuse is credited with causing the surprise.
Yes, you read that right. Biologic sales for Medtronic’s second quarter rose 9% on a reported basis while Core Spine and Interventional Spine, which consists of the company’s balloon kyphoplasty product line slipped 1% and 6%, respectively. Management said the company’s kyphoplasty sales were affected by a product supply issue re...
